83 FR 14464 - Center for Scientific Review; Notice of Closed Meeting
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health Federal Register Volume 83, Issue 65 (April 4, 2018)
National Institutes of Health
Federal Register Volume 83, Issue 65 (April 4, 2018)
| Page Range | 14464-14465 | |
| FR Document | 2018-06776 |
[Federal Register Volume 83, Number 65 (Wednesday, April 4, 2018)] [Notices] [Pages 14464-14465] From the Federal Register Online [www.thefederalregister.org] [FR Doc No: 2018-06776] ----------------------------------------------------------------------- DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Center for Scientific Review; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Center for Scientific Review Special Emphasis Panel; Member [[Page 14465]] Conflict: Neurobiology of Alcohol Toxicity and Chemosensation Date: April 11, 2018. Time: 1:00 p.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting). Contact Person: M. Catherine Bennett, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 5182, MSC 7846, Bethesda, MD 20892, 301-435-1766, [email protected]. This notice is being published less than 15 days prior to the meeting due to the timing limitations imposed by the review and funding cycle. (Catalogue of Federal Domestic Assistance Program Nos. 93.306, Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893, National Institutes of Health, HHS) Dated: March 29, 2018. David D. Clary, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2018-06776 Filed 4-3-18; 8:45 am] BILLING CODE 4140-01-P
![14464 Federal Register / Vol. 83, No. 65 / Wednesday, April 4, 2018 / Notices
qualifications to contribute to the Expertise sought for the National represented and the committee’s
accomplishment of NVAC’s objectives. Vaccine Advisory Committee: In function. Every effort is made that a
Interested candidates should accordance with the charter, persons broad representation of geographic
demonstrate a willingness to commit nominated for appointment as members areas, gender, ethnic and minority
time to NVAC activities and the ability of the NVAC should be among groups, and the disabled are given
to work constructively and effectively authorities knowledgeable in areas consideration for membership on HHS
on committees. related to vaccine safety, vaccine federal advisory committees.
Public Members: Public members are effectiveness, and vaccine supply. In Appointment to this Committee shall be
individuals who are appointed to the order to enhance the diversity of made without discrimination on the
NVAC to exercise their own expertise included in Committee basis of age, race, ethnicity, gender,
independent best judgment on behalf of discussions, NVPO is seeking sexual orientation, disability, and
the government. It is expected that nominations of individuals to serve on cultural, religious, or socioeconomic
public members will discuss and the National Vaccine Advisory status.
deliberate in a manner that is free from Committee as public members in the Individuals appointed to serve as
conflicts of interest. Public members to following disciplines/topic areas: public members of federal advisory
the NVAC shall be selected from • Vaccine research and development, committees are classified as special
individuals who are engaged in vaccine vaccine clinical trials, and vaccine government employees (SGEs). SGEs are
research or the manufacture of vaccines, regulatory science; government employees for purposes of
or who are physicians, members of • vaccine safety and post-marketing the conflict of interest laws. Therefore,
parent organizations concerned with surveillance; individuals appointed to serve as public
immunizations, representatives of state • vaccine access and financing; members of NVAC are subject to an
or local health agencies, or public health • health information technologies and ethics review. The ethics review is
organizations. immunization information systems; conducted to determine if the
Representative Members: • immunization program individual has any interests and/or
Representative members are individuals implementation and management; and activities in the private sector that may
who are appointed to the NVAC to • vaccine communications. conflict with performance of their
provide the views of industry or a How to submit nominations: official duties as a member of the
special interest group. While they may Nominations should be typewritten. The NVAC. Individuals appointed to serve
be experts in various topic areas following information should be as public members of the NVAC will be
discussed by the Committee, they included in the package of material required to disclose information
should not present their own submitted for each individual being regarding financial holdings,
viewpoints, but rather those of the nominated for consideration: (1) A letter consultancies, research grants and/or
industry or special interest group they of nomination that clearly states the contracts, and the absence of an
represent. NVAC representative name and affiliation of the nominee, the appearance of a loss of impartiality.
members shall serve specifically to basis for the nomination (i.e., specific
Dated: March 30, 2018.
represent the viewpoints or perspectives attributes which qualify the nominee for
service in this capacity); and a statement Roula Sweis,
of the vaccine manufacturing industry
or groups engaged in vaccine research or that the nominee is willing to serve as Deputy Director, National Vaccine Program
a member of the Committee (2) the Office.
the manufacture of vaccines.
This announcement is to solicit nominator’s name, address, and daytime [FR Doc. 2018–06890 Filed 4–3–18; 8:45 am]
nominations of qualified candidates to telephone number, home and/or work BILLING CODE 4150–44–P
fill positions in the public and address, telephone number, and email
representative member category of the address; (3) a current copy of the
NVAC, including positions that are nominee’s curriculum vitae (no longer DEPARTMENT OF HEALTH AND
scheduled to be vacated during the 2019 than ten pages); and (4) a short HUMAN SERVICES
calendar year. Applications received in biographical sketch (no more than 350 National Institutes of Health
response and not appointed may also be words). All required documentation
considered for future vacancies that must be received in order for a Center for Scientific Review; Notice of
occur. nomination to be considered. Closed Meeting
Travel reimbursement and Please note that nominees will not
compensation for services provided to receive updates on the status of their Pursuant to section 10(d) of the
the committee: All NVAC members are nomination. Information on nominees Federal Advisory Committee Act, as
authorized to receive the prescribed per appointed to the Committee by the amended, notice is hereby given of the
diem allowance and reimbursement for Department will be posted to the NVAC following meeting.
travel expenses that are incurred to website at http://www.hhs.gov/nvpo/ The meeting will be closed to the
attend meetings and conduct authorized nvac/members/index.html. public in accordance with the
NVAC-related business, in accordance Individuals can nominate themselves provisions set forth in sections
with standard government travel for consideration of appointment to the 552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
regulations. Members appointed to the Committee. All nominations must as amended. The grant applications and
NVAC as public members (see include the required information. the discussions could disclose
definition above) also are authorized to Incomplete nominations will not be confidential trade secrets or commercial
receive a stipend for services provided processed for consideration. The names property such as patentable material,
amozie on DSK30RV082PROD with NOTICES
at public meetings of the Committee. All of federal employees should not be and personal information concerning
other services that are performed by the nominated for consideration of individuals associated with the grant
public members outside the Committee appointment to this Committee. applications, the disclosure of which
meetings shall be provided without The Department makes every effort to would constitute a clearly unwarranted
compensation. Representative members ensure that the membership of HHS invasion of personal privacy.
(see definition above) will serve without federal advisory committees is fairly Name of Committee: Center for Scientific
compensation. balanced in terms of points of view Review Special Emphasis Panel; Member
VerDate Sep<11>2014 18:12 Apr 03, 2018 Jkt 244001 PO 00000 Frm 00055 Fmt 4703 Sfmt 4703 E:\FR\FM\04APN1.SGM 04APN1](https://thefederalregister.org/doc/83_FR_14529/page/1.svg)
![Federal Register / Vol. 83, No. 65 / Wednesday, April 4, 2018 / Notices 14465
Conflict: Neurobiology of Alcohol Toxicity Contact Person: Shiguang Yang, DVM, property such as patentable material,
and Chemosensation Ph.D., Scientific Review Officer, Division of and personal information concerning
Date: April 11, 2018. Extramural Activities, NIDCD, NIH, 6001 individuals associated with the grant
Time: 1:00 p.m. to 5:00 p.m. Executive Blvd., Room 8349, Bethesda, MD
20892, 301–496–8683, yangshi@
applications, the disclosure of which
Agenda: To review and evaluate grant
applications. nidcd.nih.gov. would constitute a clearly unwarranted
Place: National Institutes of Health, 6701 Name of Committee: National Institute on invasion of personal privacy.
Rockledge Drive, Bethesda, MD 20892 Deafness and Other Communication Name of Committee: National Institute on
(Virtual Meeting). Disorders Special Emphasis Panel; NIDCD Aging Special Emphasis Panel; Alzheimer’s
Contact Person: M. Catherine Bennett, Cochlear Implant Clinical Trial Review. Disease Drug Development.
Ph.D., Scientific Review Officer, Center for Date: May 30, 2018. Date: May 4, 2018.
Scientific Review, National Institutes of Time: 10:00 a.m. to 11:30 a.m. Time: 12:00 p.m. to 3:00 p.m.
Health, 6701 Rockledge Drive, Room 5182, Agenda: To review and evaluate grant Agenda: To review and evaluate grant
MSC 7846, Bethesda, MD 20892, 301–435– applications. applications.
1766, bennettc3@csr.nih.gov. Place: National Institutes of Health, Place: National Institute on Aging,
This notice is being published less than 15 Neuroscience Center, 6001 Executive Gateway Building, Suite 2W200, 7201
days prior to the meeting due to the timing Boulevard, Rockville, MD 20852 (Virtual Wisconsin Ave., Bethesda, MD 20892
limitations imposed by the review and Meeting). (Telephone Conference Call).
funding cycle. Contact Person: Shiguang Yang, DVM,
Contact Person: Alexander Parsadanian,
Ph.D., Scientific Review Officer, Division of
(Catalogue of Federal Domestic Assistance Ph.D., Scientific Review Officer, National
Extramural Activities, NIDCD, NIH, 6001
Program Nos. 93.306, Comparative Medicine; Institute on Aging, Gateway Building 2C/212,
Executive Blvd., Room 8349, Bethesda, MD
93.333, Clinical Research, 93.306, 93.333, 7201 Wisconsin Avenue, Bethesda, MD
20892, 301–496–8683, yangshi@
93.337, 93.393–93.396, 93.837–93.844, nidcd.nih.gov. 20892, 301–496–9666, Parsadaniana@
93.846-93.878, 93.892, 93.893, National nia.nih.gov.
Institutes of Health, HHS) Name of Committee: National Institute on
Deafness and Other Communication (Catalogue of Federal Domestic Assistance
Dated: March 29, 2018. Disorders Special Emphasis Panel; NIDCD Program Nos. 93.866, Aging Research,
Aphasia Treatment Clinical Trial Review. National Institutes of Health, HHS)
David D. Clary,
Program Analyst, Office of Federal Advisory Date: May 31, 2018.
Time: 11:00 a.m. to 1:00 p.m. Dated: March 30, 2018.
Committee Policy. Melanie J. Pantoja,
Agenda: To review and evaluate grant
[FR Doc. 2018–06776 Filed 4–3–18; 8:45 am] applications. Program Analyst, Office of Federal Advisory
BILLING CODE 4140–01–P Place: National Institutes of Health, Committee Policy.
Neuroscience Center, 6001 Executive [FR Doc. 2018–06840 Filed 4–3–18; 8:45 am]
Boulevard, Rockville, MD 20852 (Virtual
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND Meeting).
HUMAN SERVICES Contact Person: Katherine Shim, Ph.D.,
Scientific Review Officer, Division of
National Institutes of Health Extramural Activities, NIH/NIDCD, 6001 DEPARTMENT OF HEALTH AND
Executive Blvd., Room 8351, Bethesda, MD HUMAN SERVICES
National Institute on Deafness and 20892, 301–496–8683, katherine.shim@
Other Communication Disorders; nih.gov. National Institutes of Health
Notice of Closed Meetings (Catalogue of Federal Domestic Assistance
Program Nos. 93.173, Biological Research National Institute of Allergy And
Pursuant to section 10(d) of the Related to Deafness and Communicative Infectious Diseases; Notice of Closed
Federal Advisory Committee Act, as Disorders, National Institutes of Health, HHS) Meetings
amended, notice is hereby given of the Dated: March 30, 2018. Pursuant to section 10(d) of the
following meetings. Natasha M. Copeland, Federal Advisory Committee Act, as
The meetings will be closed to the Program Analyst, Office of Federal Advisory amended, notice is hereby given of the
public in accordance with the Committee Policy. following meetings.
provisions set forth in sections [FR Doc. 2018–06844 Filed 4–3–18; 8:45 am]
552b(c)(4) and 552b(c)(6), Title 5 U.S.C., The meetings will be closed to the
BILLING CODE 4140–01–P public in accordance with the
as amended. The grant applications and
the discussions could disclose provisions set forth in sections
confidential trade secrets or commercial 552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
DEPARTMENT OF HEALTH AND as amended. The grant applications and
property such as patentable material, HUMAN SERVICES
and personal information concerning the discussions could disclose
individuals associated with the grant National Institutes of Health confidential trade secrets or commercial
applications, the disclosure of which property such as patentable material,
would constitute a clearly unwarranted National Institute on Aging; Notice of and personal information concerning
invasion of personal privacy. Closed Meeting individuals associated with the grant
applications, the disclosure of which
Name of Committee: National Institute on Pursuant to section 10(d) of the would constitute a clearly unwarranted
Deafness and Other Communication Federal Advisory Committee Act, as invasion of personal privacy.
Disorders Special Emphasis Panel; NIDCD amended, notice is hereby given of the
P50 Review. following meeting. Name of Committee: National Institute of
Date: May 9, 2018. Allergy and Infectious Diseases Special
amozie on DSK30RV082PROD with NOTICES
The meeting will be closed to the
Time: 11:00 a.m. to 3:00 p.m. Emphasis Panel; PHS 2018–1 Small Business
public in accordance with the Innovation Research (SBIR) Program Phase II
Agenda: To review and evaluate grant
applications.
provisions set forth in sections Contract Solicitation (TOPIC 35) (N01).
Place: National Institutes of Health, 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., Date: April 23, 2018.
Neuroscience Center, 6001 Executive as amended. The grant applications and Time: 12:00 p.m. to 5:00 p.m.
Boulevard, Rockville, MD 20852 (Virtual the discussions could disclose Agenda: To review and evaluate contract
Meeting). confidential trade secrets or commercial proposals.
VerDate Sep<11>2014 18:12 Apr 03, 2018 Jkt 244001 PO 00000 Frm 00056 Fmt 4703 Sfmt 4703 E:\FR\FM\04APN1.SGM 04APN1](https://thefederalregister.org/doc/83_FR_14529/page/2.svg)
Document Created: 2018-11-01 09:11:23
Document Modified: 2018-11-01 09:11:23
| Category | Regulatory Information | |
| Collection | Federal Register | |
| sudoc Class | AE 2.7: GS 4.107: AE 2.106: | |
| Publisher | Office of the Federal Register, National Archives and Records Administration | |
| Section | Notices | |
| Dates | April 11, 2018. | |
| FR Citation | 83 FR 14464 |
2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR